RUBICON RESEARCH LIMITED (RUBICON) Share Price Rises 2.46% Today

RUBICON RESEARCH LIMITED Share Price is at Rs 1,862.45, up Rs 44.8 or 2.46% from the previous close of Rs 1,817.65. The company’s market capitalisation stands at Rs 29,891.75 crore.

The stock opened at Rs 1,834.3, traded between Rs 1,829.4 and Rs 1,862.45, and the current price matches the session high in the supplied snapshot. Turnover was Rs 0.63 crore. The data confirms the gain, but it does not provide a company-specific trigger for the move.

Even without a stated catalyst, today’s move is drawing attention because valuation and profitability metrics stand out within the Healthcare and Pharmaceuticals & Drugs space. RUBICON RESEARCH LIMITED Share Price is being watched not only for the day’s rise, but also because its P/E and P/B are well above industry medians while ROE and ROCE are materially stronger than the broader benchmark set.

RUBICON RESEARCH LIMITED Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,862.45
Previous Close	Rs 1,817.65
Today's Move	Rs 44.8 (+2.46%)
Open	Rs 1,834.3
High	Rs 1,862.45
Low	Rs 1,829.4
Turnover	Rs 0.63 crore
Market Capitalisation	Rs 29,891.75 crore
Market Cap Category	Large Cap

RUBICON RESEARCH LIMITED (RUBICON) rose to Rs 1,862.45 from the previous close of Rs 1,817.65, a move of Rs 44.8 or 2.46%. The stock opened at Rs 1,834.3, reached a high of Rs 1,862.45, recorded a low of Rs 1,829.4.

RUBICON RESEARCH LIMITED Share Price rose from Rs 1,817.65 to Rs 1,862.45, a gain of Rs 44.8 or 2.46%. The stock opened at Rs 1,834.3, dipped to Rs 1,829.4, and then climbed to Rs 1,862.45. Because the current price equals the day’s high, the available snapshot shows the stock holding at the top of its intraday range.

This indicates a firm session rather than a move that quickly faded after the open. The price stayed above the previous close across the observed range, and the gap between open and high was closed during the session. Turnover of Rs 0.63 crore gives additional context, though the dataset does not say whether the move was driven by results, news flow, sector action, or any other event.

For readers tracking stocks rising today, the immediate takeaway is simple: RUBICON RESEARCH LIMITED Share Price posted a clear same-day gain and remained strong into the captured reading.

RUBICON RESEARCH LIMITED (RUBICON) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 29,891.75 crore
P/E Ratio	104.39x
P/B Ratio	22.41x
ROE	27.84%
ROCE	29.22%
EPS	Rs 17.41
Book Value Per Share	Rs 81.09
Dividend Yield	0.08%

RUBICON RESEARCH LIMITED (RUBICON) fundamental metrics show P/E 104.39x, P/B 22.41x, ROE 27.84%, ROCE 29.22%. These figures provide context only and are not a buy or sell signal.

RUBICON RESEARCH LIMITED has a market capitalisation of Rs 29891.75 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 104.39x, P/B at 22.41x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.84% and ROCE of 29.22%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 17.41, book value per share of Rs 81.09, dividend yield of 0.08%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.92x, median ROE of 11.81%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	104.39x
Benchmark Median P/E	30.92x
Benchmark Average P/E	48.02x
Benchmark P/E Range	3.87x to 667.16x
Company P/B Ratio	22.41x
Benchmark Median P/B	2.88x
Company ROE	27.84%
Benchmark Median ROE	11.81%
Company ROCE	29.22%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 29,891.75 crore
Benchmark Median Market Cap	Rs 683.05 crore

RUBICON RESEARCH LIMITED (RUBICON) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

RUBICON RESEARCH LIMITED (RUBICON) has a P/E ratio of 104.39x, which is above the benchmark median of 30.92x, a difference of +237.61%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

RUBICON RESEARCH LIMITED (RUBICON) has a ROE of 27.84%, which is above the benchmark median of 11.81%, a difference of +135.73%. RUBICON RESEARCH LIMITED (RUBICON) has a ROCE of 29.22%, which is above the benchmark median of 13.65%, a difference of +114.07%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,60,696.31	38.8	5.43	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,46,062.83	83.91	13.89	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,91,515.22	86.82	21.1	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,18,403.7	25.69	4.3	19.69	21.39
Cipla Ltd.	CIPLA	1,14,554.33	33.94	3.25	11.83	16

RUBICON RESEARCH LIMITED (RUBICON) has a P/E ratio of 104.39x compared with the displayed peer median of 38.8x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.84% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 29.22% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. RUBICON RESEARCH LIMITED (RUBICON) has a market capitalisation of Rs 29,891.75 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching RUBICON RESEARCH LIMITED

• RUBICON RESEARCH LIMITED Share Price is up 2.46% to Rs 1,862.45.
• The stock traded between Rs 1,829.4 and Rs 1,862.45 after opening at Rs 1,834.3.
• P/E of 104.39 and P/B of 22.41 are above same-industry medians.
• ROE of 27.84 and ROCE of 29.22 are above industry medians.
• Market cap of Rs 29,891.75 crore is above both the industry median and average.

About RUBICON RESEARCH LIMITED

RUBICON RESEARCH LIMITED operates in Healthcare and is classified under Pharmaceuticals & Drugs. In this dataset, the company stands out less for a disclosed event and more for its market profile: larger than the typical same-industry company, stronger on return ratios than broad benchmarks, and priced at a premium on valuation multiples.

That is why the current move is being assessed mainly through comparative metrics rather than a stated corporate announcement. For market participants, the stock sits at the intersection of price momentum, valuation discipline, and sector benchmarking.

Track RUBICON RESEARCH LIMITED Share Price on Univest

Use RUBICON RESEARCH LIMITED (RUBICON) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Use the RUBICON RESEARCH LIMITED (RUBICON) live share-price page, the Univest top gainers screener, and Univest market blogs to follow live price moves, valuation metrics, sector comparisons, and related market coverage in one place.

Frequently Asked Questions

Why is RUBICON RESEARCH LIMITED Share Price rising today?

Ans. RUBICON RESEARCH LIMITED Share Price is up 2.46% today at Rs 1,862.45 versus the previous close of Rs 1,817.65. The supplied data confirms the rise, but it does not identify a company-specific catalyst.

What is RUBICON RESEARCH LIMITED Share Price today?

Ans. The stock is at Rs 1,862.45. It opened at Rs 1,834.3, touched a low of Rs 1,829.4, and traded up to Rs 1,862.45, which is also the day’s high in the supplied snapshot.

How does valuation compare with the industry?

Ans. RUBICON trades at a P/E of 104.39 versus the same-industry median of 30.92 and average of 48.02. Its P/B is 22.41 versus an industry median of 2.88 and average of 4.34, indicating a premium valuation on the supplied data.

How strong are the profitability metrics?

Ans. ROE is 27.84% and ROCE is 29.22%. Both are above the same-industry median levels of 11.81% and 13.65%, and also above the industry averages of 11.21% and 13.76%. ROE stands at 27.84%.

How does RUBICON compare with the displayed pharma peers?

Ans. RUBICON has a higher P/E than Sun Pharma, Divi's, Torrent, Zydus, and Cipla, and it also shows higher ROE and ROCE than each of these displayed peers. Its market capitalisation of Rs 29,891.75 crore is smaller than all five.